Current Affairs Quiz 30 June 2026

Statements 1 and 4 are correct — Netra's IOC was granted in 2017 and its FOC followed on 25 June 2026, confirming full combat readiness, while the future Netra Mk-2 is indeed planned on the Airbus A321 platform, distinct from the current Mk-1's base. Statement 2 is incorrect: Netra's airframe is the Embraer EMB-145I of Brazilian origin, not an HAL-built platform — an agency-misattribution trap that conflates indigenous radar/mission-suite design with indigenous airframe manufacture. Statement 3 is also incorrect: India is the fifth country with indigenous AEW&C capability, after the United States, Russia, Israel, and China, not the fourth — a one-off numerical undercount trap.

For losses up to ₹50,000, customers may claim 85% of the loss as compensation, capped at ₹25,000, available only once in a lifetime. Since 85% of ₹45,000 works out to ₹38,250 — well above the ₹25,000 ceiling — the customer receives the flat capped amount rather than the percentage figure. Option A wrongly assumes full reimbursement, when the 85%-with-cap formula applies uniformly; Option B substitutes a plausible but incorrect 50% rate in place of the actual 85% rule; and Option D inverts the framework's scope, since credential-theft fraud ("fraudulent EBT") is precisely the new category the 2026 amendment added beyond the 2017 circular's unauthorised-transactions-only coverage.

Statements 1, 2, and 4 are correct: the mandate already covers 300 top brands including Aciloc and Calpol; vaccines, narcotics/addictive drugs, and anti-cancer drugs face a July 2027 deadline while antimicrobials follow by July 2028 under a phased, risk-prioritised rollout; and India's vaccine regulation stands at WHO Maturity Level 3 (the second-highest tier), with Level 4 as the target for full international trust in pharmaceutical exports. Statement 3 is incorrect — the mandated QR/bar code must carry the brand name, generic name, manufacturer's name and address, batch number, manufacturing/expiry dates, and manufacturing licence number, but not the retail price, the reverse of what the statement claims.

The Space Cooperation MoU on satellite applications, remote sensing, and disaster management falls under India's space-agency framework; the Agricultural Research Work Plan (2026–2031) was signed via ICAR with the Seychelles Agriculture Department; Diplomatic Capacity Building was institutionalised through the Sushma Swaraj Institute of Foreign Service; and the Extradition Treaty falls within the MEA's Legal and Treaties Division governing fugitive extradition. Option B swaps the ICAR and space-cooperation pairing, Option C swaps SSIFS with the agricultural agency pairing, and Option D scrambles all four pairings entirely, testing genuine recall over guesswork.

The correct sequence is: the framework agreement for the interim trade deal was signed in February 2026 (2); soon after, the U.S. Supreme Court invalidated the IEEPA-based reciprocal tariff system (1); in March 2026, USTR initiated the two Section 301 investigations (3); and in early June 2026, the U.S. proposed a 12.5% tariff on 54 countries under the forced-labour probe (4). Option B reverses the first two events, wrongly placing the Supreme Court ruling before the framework signing, when the ruling actually disrupted an already-signed agreement. Option C delays the ruling until after the Section 301 investigations began, when it actually came first and arguably catalysed the regulatory uncertainty behind them. Option D omits the framework signing from its correct starting position.